For the third year running DDW is organising a series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).

This programme, Creating Cures: The role of lab automation in successful drug discovery at SLAS2026 – will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February.

Speakers confirmed:

• Mel Leveridge, Vice President, Assays, Profiling & Cell Sciences, AstraZeneca: The Role of Automation in Discovery at AstraZeneca
• James White, Collaborative Communications: Interoperable Automation: Real-Time Dataflows to Close DMTA Cycles
• Dr Li Medera, CEO and Founder, Medera: From Animal Models to Human Mini-Hearts: How Automated Human-Based Testing is Revolutionising Drug Discovery
• Hansjoerg Haas, Sr Director and General Manager, Laboratory Automation, Thermo Fisher Scientific: FromData to Decisions: Digital-Ready Laboratories Powered by Automation

The track is sponsored by Collaborative Drug Discovery (CDD), Brooks Automation and Thermo Fisher Scientific.

Let us know if you’re attending by registering your interest.